What is Artiva Biotherapeutics, Inc. Common Stock (ARTV) stock price today?

Artiva Biotherapeutics, Inc. Common Stock (ARTV) currently trades at $10.24 per share. The stock has a market capitalization of $255.08M and a P/E ratio of —x.

Is ARTV stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Artiva Biotherapeutics, Inc. Common Stock has a Smart Value Score of 23/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

ARTV

Artiva Biotherapeutics, Inc. Common Stock

NASDAQ: ARTV · HEALTHCARE · BIOTECHNOLOGY

$10.24

+17.43% today

Updated 2026-04-30

Market cap

$255.08M

P/E ratio

—

P/S ratio

8.11x

EPS (TTM)

$-3.43

Dividend yield

—

52W range

$1 – $15

Volume

0.3M

Market cap

$255.08M

P/E ratio

—

P/S ratio

8.11x

EPS (TTM)

$-3.43

Dividend yield

—

52W range

$1 – $15

Volume

0.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

3.7

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$17.00

+66.02%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-15.15M

- Revenue declining -100.00% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$4.93M	$33.49M	$251000.00	$0.00	$0.00
Net income	$-58.39M	$-27.70M	$-58.49M	$-83.86M	$-20.77M
EPS	—	—	—	—	$-3.43
Free cash flow	$-57.13M	$-50.69M	$-55.67M	$-79.34M	$-15.15M
Profit margin	-1,184.10%	-82.69%	-23,303.98%	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ARTV	$255.08M	23	3.7	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Artiva Biotherapeutics, Inc. Common Stock trades at $10.24. Our Smart Value Score of 23/100 indicates the stock is weak.

Frequently asked questions

What is Artiva Biotherapeutics, Inc. Common Stock's stock price?

Artiva Biotherapeutics, Inc. Common Stock (ARTV) trades at $10.24.

Is Artiva Biotherapeutics, Inc. Common Stock overvalued?

Smart Value Score 23/100 (Grade F, Strong Sell).

What is the price target of Artiva Biotherapeutics, Inc. Common Stock (ARTV)?

The analyst target price is $17.00, representing +66.0% upside from the current price of $10.24.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio8.11x

ROE-56.60%

Beta—

50D MA$6.68

200D MA$4.30

Shares out0.02B

Float0.00B

Short ratio—

Avg volume0.3M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ARTV vs LLY →ARTV vs JNJ →ARTV vs ABBV →Stock screener →